Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease

Adalimumab (ADA) is applied to induce remission in patients with Crohn's disease (CD) naïve to chimeric anti-tumor necrosis factor-α (anti-TNF-α), infliximab or patients with loss of response to scheduled maintenance infliximab. Adsorptive granulocyte and monocyte apheresis (GMA) depletes eleva...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ozeki, Keiji, Tanida, Satoshi, Mizoshita, Tsutomu, Tsukamoto, Hironobu, Ebi, Masahide, Mori, Yoshinori, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: S. Karger AG 2012
Onderwerpen:
Published online: December, 2012
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551391/
https://ncbi.nlm.nih.gov/pubmed/23341799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000346312
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items